We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
-8.86%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$220M
AUM Growth
-$17M
Cap. Flow
-$6.31M
Cap. Flow %
-2.87%
Top 10 Hldgs %
36.95%
Holding
108
New
33
Increased
19
Reduced
16
Closed
31

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$8.56M
2
ABT icon
Abbott
ABT
+$4.95M
3
AET
Aetna Inc
AET
+$4.28M
4
ATHN
Athenahealth, Inc.
ATHN
+$4.12M
5
SHPG
Shire pic
SHPG
+$3.89M

Top Sells

Rank Stock Value
1
CI icon
Cigna
CI
+$8.41M
2
BRKR icon
Bruker
BRKR
+$6.43M
3
TFX icon
Teleflex
TFX
+$5.58M
4
LIVN icon
LivaNova
LIVN
+$4.01M
5
NUVA
NuVasive, Inc.
NUVA
+$3.63M

Sector Composition

Rank Sector Weight
1 Healthcare 59.86%
2 Financials 2.04%
3 Industrials 1.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALIM
101
DELISTED
Alimera Sciences
ALIM
– –
-8,640
Closed -$314K
ASXC
102
DELISTED
Asensus Surgical, Inc.
ASXC
– –
-62,339
Closed -$2.01M
NUVA
103
DELISTED
NuVasive, Inc.
NUVA
– –
-80,000
Closed -$3.63M
XENT
104
DELISTED
Intersect ENT, Inc
XENT
– –
-55,000
Closed -$1.24M
SPNC
105
CALL
DELISTED
Spectranetics Corp
SPNC
– –
-20,000
Closed -$301K
GI
106
DELISTED
EndoChoice Holdings, Inc.
GI
– –
-40,000
Closed -$334K
AFFX
107
DELISTED
Affymetrix Inc
AFFX
– –
-259,309
Closed -$2.62M
QGENF
108
DELISTED
QIAGEN NV
QGENF
– –
-78,668
Closed -$2.17M
1 2 3 4
5

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q1 2016 Portfolio in Review

As of Q1 2016, Pura Vida Investments held 108 positions worth $220M, down 7.2% from $237M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Pura Vida Investments's Q1 2016 filing shows 33 new, 19 increased, 16 reduced and 31 closed positions. Its largest new stake was Abbott: 125,000 shares worth $5.23M. The largest sale was Cigna, an estimated $8.41M.

By sector, the portfolio is most concentrated in Healthcare at 60% of assets, up from 56% a quarter earlier, followed by Financials and Industrials.

  • Pura Vida Investments's largest Q1 2016 buy was Abbott: 125,000 shares worth $5.23M.
  • Pura Vida Investments added most to Allergan plc in Q1 2016, an estimated $8.56M increase.
  • Pura Vida Investments's biggest Q1 2016 reduction was Teleflex, cutting an estimated $5.58M.
  • Pura Vida Investments fully exited Cigna in Q1 2016, selling an estimated $8.41M.
  • Pura Vida Investments's ten largest holdings make up 37% of its $220M portfolio in Q1 2016.
  • Pura Vida Investments opened 33 new positions and closed 31 in Q1 2016.
  • Pura Vida Investments's portfolio value fell 7.2% quarter-over-quarter to $220M.

Based on Pura Vida Investments's 13F filing for Q1 2016, filed 16 May 2016.